XML 139 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative Instruments
12 Months Ended
Sep. 30, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments
Derivative Instruments
In June 2013, the Company entered into foreign exchange contracts to reduce its exposure to changes in foreign exchange rates associated with an order for multiple automated sample management systems. The Company concluded that these foreign currency contracts met the criteria to qualify as a cash flow hedge. Accordingly, the Company reflected changes in the fair value of the effective portion of these foreign currency contracts in accumulated other comprehensive income. In the third quarter of fiscal year 2014, the Company reclassified the realized gain of $0.1 million on these contracts into revenue to coincide with recognition of the hedged transaction. The Company did not recognize any amounts related to ineffectiveness in the results of operations for the fiscal years ended September 30, 2014 or 2013 with respect to these contracts. The Company did not have any notional amounts outstanding under foreign currency contracts that qualify for cash flow hedge accounting at September 30, 2014.
The Company has transactions and balances denominated in currencies other than the U.S. dollar. Most of these transactions or balances are denominated in Euros, British Pounds and a variety of Asian currencies. These transactions and balances, including short-term advances between the Company and its subsidiaries, subject the Company's operations to exposure from exchange rate fluctuations. The impact of currency exchange rate movement can be positive or negative in any period. The Company mitigates the impact of potential currency translation gains and losses on short-term intercompany advances through timely settlement of each transaction, generally within 30 days.
The Company also enters into foreign exchange contracts to reduce its exposure to currency translation. Under forward contract arrangements, the Company typically agrees to purchase a fixed amount of U.S. dollars in exchange for a fixed amount of a foreign currency on specified dates with maturities of three months or less. These transactions do not qualify for hedge accounting. Net gains and losses recorded as a component of "Other income, net" in the Consolidated Statements of Operations related to these contracts is as follows for the fiscal years ended September 30, 2014, 2013 and 2012 (in thousands):
 
 
Year ended September 30,
 
 
2014
 
2013
 
2012
Realized gains (losses) on derivative instruments not designated as hedging instruments
 
$
185

 
$
123

 
$
(151
)

The Company had the following notional amounts outstanding under foreign currency contracts that do not qualify for hedge accounting at September 30, 2014 and 2013 (in thousands):
September 30, 2014:    
Buy Currency
 
Notional Amount
of Buy Currency
 
Sell Currency
 
Maturity
 
Notional Amount
of Sell Currency
 
Fair Value of
Assets
 
Fair Value of
Liabilities
U.S. dollar
 
1,736

 
Japanese yen
 
October 2014 to December 2014
 
190,000

 
$

 
$
11

U.S. dollar
 
1,395

 
Euro
 
October 2014
 
1,100

 

 
16

U.S. dollar
 
656

 
Taiwan dollar
 
October 2014
 
20,000

 

 
5

U.S. dollar
 
650

 
British pound
 
October 2014
 
400

 

 
5

U.S. dollar
 
731

 
Israeli shekel
 
October 2014
 
2,700

 

 
5

U.S. dollar
 
76

 
Korean won
 
October 2014
 
80,000

 

 
1

British pound
 
3,513

 
Euro
 
October 2014
 
4,500

 

 
15

 
 
 
 
 
 
 
 
 
 
$

 
$
58

    
September 30, 2013:
Buy Currency
 
Notional Amount
of Buy Currency
 
Sell Currency
 
Maturity
 
Notional Amount
of Sell Currency
 
Fair Value of
Assets
 
Fair Value of
Liabilities
U.S. dollar
 
2,762

 
Japanese yen
 
October 2013 to December 2013
 
273,000

 
$
8

 
$

Korean won
 
740,000

 
U.S. dollar
 
October 2013
 
688

 

 
2

U.S. dollar
 
304

 
Israeli shekel
 
October 2013
 
1,075

 

 
3

U.S. dollar
 
231

 
Singapore dollar
 
October 2013
 
290

 

 

 
 
 
 
 
 
 
 
 
 
$
8

 
$
5


The fair values of the forward contracts described above are recorded in the Company's Consolidated Balance Sheets as prepaid expenses and other current assets and accrued expenses and other current liabilities.